Cutler Group’s Elevance Health ELV Stock Holding History

Cutler Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-300	Closed	-$1K	–	5042
2022 Q2	$1K	Sell	300 -700	-70%	-$346K	﹤0.01%	4551
2022 Q1	$4K	Buy	+1,000	New	+$457K	﹤0.01%	4256
2021 Q4	–	Sell	-1,000	Closed	-$20K	–	5525
2021 Q3	$20K	Buy	+1,000	New	+$380K	﹤0.01%	3335
2020 Q4	–	Sell	-500	Closed	-$5K	–	4965
2020 Q3	$5K	Hold	500	–	–	﹤0.01%	3481
2020 Q2	$11K	Hold	500	–	–	﹤0.01%	2801
2020 Q1	$21K	Sell	500 -4,200	-89%	-$1.14M	﹤0.01%	2266
2019 Q4	$6K	Sell	4,700 -1,600	-25%	-$440K	﹤0.01%	2926
2019 Q3	$78K	Sell	6,300 -2,100	-25%	-$575K	0.01%	1220
2019 Q2	$64K	Buy	8,400 +5,600	+200%	+$1.53M	0.01%	1364
2019 Q1	$12K	Buy	+2,800	New	+$810K	﹤0.01%	2376
2017 Q1	–	Sell	-5,000	Closed	-$1K	–	6565
2016 Q4	$1K	Hold	5,000	–	–	﹤0.01%	5957
2016 Q3	$34K	Hold	5,000	–	–	﹤0.01%	2849
2016 Q2	$39K	Buy	+5,000	New	+$684K	﹤0.01%	2610

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Cutler Group's ELV Position: Q4 2022 in Review

Cutler Group sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 46 shares — an estimated $20K sold.

Cutler Group first reported a position in ELV in Q2 2016 and held it in 15 quarters. The position peaked at $1.76M in Q2 2019. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

Cutler Group reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
Cutler Group sold 46 Elevance Health shares in Q4 2022, an estimated $20K.
Cutler Group first reported a position in Elevance Health in Q2 2016 and held it in 15 quarters.
Cutler Group's Elevance Health position peaked at $1.76M in Q2 2019.
1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.